Vanguard Group’s Xenon Pharmaceuticals XENE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.3M | Buy |
873,228
+536,714
| +159% | +$16.8M | ﹤0.01% | 2405 |
|
|
2025
Q1 | $11.3M | Sell |
336,514
-6,265
| -2% | -$210K | ﹤0.01% | 2777 |
|
|
2024
Q4 | $13.4M | Sell |
342,779
-1,586
| -0.5% | -$62.2K | ﹤0.01% | 2789 |
|
|
2024
Q3 | $13.6M | Buy |
344,365
+3,213
| +0.9% | +$126K | ﹤0.01% | 2803 |
|
|
2024
Q2 | $13.3M | Buy |
341,152
+5,517
| +2% | +$215K | ﹤0.01% | 2764 |
|
|
2024
Q1 | $14.4M | Buy |
335,635
+12,140
| +4% | +$523K | ﹤0.01% | 2761 |
|
|
2023
Q4 | $14.9M | Buy |
323,495
+56,669
| +21% | +$2.61M | ﹤0.01% | 2728 |
|
|
2023
Q3 | $9.11M | Buy |
266,826
+5,473
| +2% | +$187K | ﹤0.01% | 2937 |
|
|
2023
Q2 | $10.1M | Buy |
261,353
+11,999
| +5% | +$462K | ﹤0.01% | 2940 |
|
|
2023
Q1 | $8.92M | Buy |
249,354
+57,278
| +30% | +$2.05M | ﹤0.01% | 2995 |
|
|
2022
Q4 | $7.57M | Buy |
192,076
+6,884
| +4% | +$271K | ﹤0.01% | 3086 |
|
|
2022
Q3 | $6.69M | Buy |
185,192
+1,347
| +0.7% | +$48.6K | ﹤0.01% | 3158 |
|
|
2022
Q2 | $5.59M | Buy |
183,845
+20,377
| +12% | +$620K | ﹤0.01% | 3321 |
|
|
2022
Q1 | $5M | Buy |
163,468
+10,102
| +7% | +$309K | ﹤0.01% | 3529 |
|
|
2021
Q4 | $4.79M | Buy |
153,366
+46,174
| +43% | +$1.44M | ﹤0.01% | 3637 |
|
|
2021
Q3 | $1.64M | Buy |
107,192
+3,756
| +4% | +$57.4K | ﹤0.01% | 4121 |
|
|
2021
Q2 | $1.93M | Sell |
103,436
-3,359
| -3% | -$62.5K | ﹤0.01% | 3972 |
|
|
2021
Q1 | $1.91M | Buy |
106,795
+9,232
| +9% | +$165K | ﹤0.01% | 3871 |
|
|
2020
Q4 | $1.5M | Buy |
97,563
+2,670
| +3% | +$41.1K | ﹤0.01% | 3728 |
|
|
2020
Q3 | $1.05M | Buy |
94,893
+150
| +0.2% | +$1.66K | ﹤0.01% | 3648 |
|
|
2020
Q2 | $1.19M | Buy |
+94,743
| New | +$1.19M | ﹤0.01% | 3569 |
|